Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  261 results for ""Lymphoma, Follicular""

Your Filters

Publisher : american society of clinical oncology
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Long-Term Follow-Up of the RESORT Study (E4402): A Randomized Phase III Comparison of Two Different Rituximab Dosing Strategies for Low-Tumor Burden Follicular Lymphoma.

  • Authors : Kahl BS; Washington University School of Medicine, St Louis, MO.; Jegede OA

Subjects: Lymphoma, Follicular*/Lymphoma, Follicular*/Lymphoma, Follicular*/pathology ; Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/therapeutic use; Humans

  • Source: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Mar 01; Vol. 42 (7), pp. 774-778. Date Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model:

Record details

Read More Add to Saved list
×
Academic Journal

Minimal Residual Disease Status Predicts Outcome in Patients With Previously Untreated Follicular Lymphoma: A Prospective Analysis of the Phase III GALLIUM Study.

  • Authors : Pott C; University Hospital Schleswig-Holstein, Kiel, Germany.; Jurinovic V

Subjects: Gallium*/Gallium*/Gallium*/therapeutic use ; Lymphoma, Follicular*; Humans

  • Source: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Feb 10; Vol. 42 (5), pp. 550-561. Date Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model:

Record details

Read More Add to Saved list
×
Academic Journal

ROSEWOOD: A Phase II Randomized Study of Zanubrutinib Plus Obinutuzumab Versus Obinutuzumab Monotherapy in Patients With Relapsed or Refractory Follicular Lymphoma.

  • Authors : Zinzani PL; IRCCS Azienda Ospedaliero-Universitaria di Bologna Istituto di Ematologia 'Seràgnoli' and Dipartimento di Scienze Mediche e Chirurgiche, Università di Bologna, Bologna, Italy.; Mayer J

Subjects: Lymphoma, Follicular* ; Piperidines* ; Pyrazoles*

  • Source: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2023 Nov 20; Vol. 41 (33), pp. 5107-5117. Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model:

Record details

Read More Add to Saved list
×
Academic Journal

Estimating the Lifetime Treatment Burden of Patients With Follicular Lymphoma: A Retrospective Study Using Real-World Multicenter Data.

  • Authors : Rajamäki A; Institute of Clinical Medicine, Faculty of Health Sciences, University of Eastern Finland, Kuopio, Finland.; Hujo M

Subjects: Lymphoma, Follicular*/Lymphoma, Follicular*/Lymphoma, Follicular*/diagnosis ; Lymphoma, Follicular*/Lymphoma, Follicular*/Lymphoma, Follicular*/epidemiology ; Lymphoma, Follicular*/Lymphoma, Follicular*/Lymphoma, Follicular*/therapy

  • Source: JCO clinical cancer informatics [JCO Clin Cancer Inform] 2023 Sep; Vol. 7, pp. e2300067.Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101708809 Publication Model:

Record details

Read More Add to Saved list
×
Academic Journal

Donor-Derived Follicular Lymphoma After Kidney Transplantation: A Case Report.

  • Authors : Singhal K; Division of Oncology, Department of Medicine, Washington University School of Medicine, St Louis, MO.; Watkins MP

Subjects: Kidney Transplantation*/Kidney Transplantation*/Kidney Transplantation*/adverse effects ; Lymphoma, Follicular*/Lymphoma, Follicular*/Lymphoma, Follicular*/diagnosis ; Lymphoma, Follicular*/Lymphoma, Follicular*/Lymphoma, Follicular*/etiology

  • Source: JCO precision oncology [JCO Precis Oncol] 2023 Sep; Vol. 7, pp. e2300177.Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101705370 Publication Model:

Record details

Read More Add to Saved list
×
Academic Journal

Randomized Phase III Trial Evaluating Subcutaneous Rituximab for the First-Line Treatment of Low-Tumor Burden Follicular Lymphoma: Results of a LYSA Study.

  • Authors : Cartron G; Department of Hematology, UMR CNRS 5535, University Hospital, Montpellier, France.; Bachy E

Subjects: Lymphoma, Follicular*/Lymphoma, Follicular*/Lymphoma, Follicular*/pathology; Humans ; Rituximab

  • Source: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2023 Jul 01; Vol. 41 (19), pp. 3523-3533. Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model:

Record details

Read More Add to Saved list
×
Academic Journal

Relevance of Bone Marrow Biopsies for Response Assessment in US National Cancer Institute National Clinical Trials Network Follicular Lymphoma Clinical Trials.

  • Authors : Rutherford SC; Weill Department of Medicine, Division of Hematology and Medical Oncology, Meyer Cancer Center, Weill Cornell Medicine and NewYork-Presbyterian Hospital, New York, NY.; Yin J

Subjects: Lymphoma, Follicular*/Lymphoma, Follicular*/Lymphoma, Follicular*/drug therapy; United States ; Humans

  • Source: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2023 Jan 10; Vol. 41 (2), pp. 336-342. Date Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model:

Record details

Read More Add to Saved list
×
Academic Journal

Six-Year Results From RELEVANCE: Lenalidomide Plus Rituximab (R 2 ) Versus Rituximab-Chemotherapy Followed by Rituximab Maintenance in Untreated Advanced Follicular Lymphoma.

Subjects: Lymphoma, Follicular* ; Neoplasms, Second Primary*/Neoplasms, Second Primary*/Neoplasms, Second Primary*/etiology; Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/adverse effects

  • Source: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2022 Oct 01; Vol. 40 (28), pp. 3239-3245. Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model:

Record details

Read More Add to Saved list
×
Academic Journal

Risk Stratification of Stage I Grade 3 Endometrioid Endometrial Carcinoma in the Era of Molecular Classification.

  • Authors : Zammarrelli WA 3rd; Gynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY.; Kim SH

Subjects: Carcinoma, Endometrioid*/Carcinoma, Endometrioid*/Carcinoma, Endometrioid*/genetics ; Endometrial Neoplasms*/Endometrial Neoplasms*/Endometrial Neoplasms*/genetics ; Lymphoma, Follicular*

  • Source: JCO precision oncology [JCO Precis Oncol] 2022 Oct; Vol. 6, pp. e2200194.Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101705370 Publication Model:

Record details

Read More Add to Saved list
×
Academic Journal

Long-Term Follow-Up of Combination of B-Cell Maturation Antigen and CD19 Chimeric Antigen Receptor T Cells in Multiple Myeloma.

  • Authors : Wang Y; Blood Diseases Institute, Xuzhou Medical University, Xuzhou, China.; Department of Hematology, the Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.

Subjects: Lymphoma, Follicular* ; Multiple Myeloma*/Multiple Myeloma*/Multiple Myeloma*/drug therapy ; Receptors, Chimeric Antigen*

  • Source: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2022 Jul 10; Vol. 40 (20), pp. 2246-2256. Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model:

Record details

Read More Add to Saved list
×
  • 1-10 of  261 results for ""Lymphoma, Follicular""